Thomas Steyer’s Bristol-Myers Squibb BMY Stock Holding History

Thomas Steyer’s Portfolio BMY Stock Details BMY Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q1	–	Sell	-3,188,000	Closed	-$180M	–	149
2024 Q4	$180M	Buy	+3,188,000	New	+$178M	0.79%	42
2021 Q1	–	Sell	-250,000	Closed	-$15.5M	–	239
2020 Q4	$15.5M	Sell	250,000 -3,500,000	-93%	-$215M	0.09%	97
2020 Q3	$226M	Buy	3,750,000 +125,000	+3%	+$7.52M	1.56%	24
2020 Q2	$213M	Buy	+3,625,000	New	+$217M	1.71%	21
2018 Q1	–	Sell	-1,192,500	Closed	-$73.1M	–	92
2017 Q4	$73.1M	Sell	1,192,500 -162,500	-12%	-$10.2M	0.59%	34
2017 Q3	$86.4M	Buy	+1,355,000	New	+$79.1M	0.77%	34
2017 Q2	–	Sell	-442,500	Closed	-$24.1M	–	84
2017 Q1	$24.1M	Buy	442,500 +132,500	+43%	+$7.27M	0.26%	52
2016 Q4	$18.1M	Buy	+310,000	New	+$16.9M	0.21%	46

Other funds holding BMY

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Capital International Investors Los Angeles, California $484B AUM 34.9% 1-Year Est. Return

Charles Schwab San Francisco, California $751B AUM 38.74% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Norges Bank Oslo, Norway $1T AUM

Ameriprise Minneapolis, Minnesota $495B AUM 43.24% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Thomas Steyer's BMY Position: Q1 2025 in Review

Thomas Steyer sold out of Bristol-Myers Squibb (BMY) in Q1 2025, closing a stake of 3,188,000 shares — an estimated $180M sold.

Thomas Steyer first reported a position in BMY in Q4 2016 and held it in 8 quarters. The position peaked at $226M in Q3 2020. 2,481 funds tracked by Wall St. Rank hold BMY as of Q1 2025.

Thomas Steyer reported no remaining Bristol-Myers Squibb position as of Q1 2025 after selling out during the quarter.
Thomas Steyer sold 3,188,000 Bristol-Myers Squibb shares in Q1 2025, an estimated $180M.
Thomas Steyer first reported a position in Bristol-Myers Squibb in Q4 2016 and held it in 8 quarters.
Thomas Steyer's Bristol-Myers Squibb position peaked at $226M in Q3 2020.
2,481 funds tracked by Wall St. Rank held Bristol-Myers Squibb as of Q1 2025.

Based on Farallon Capital Management's 13F filing for Q1 2025, filed 15 May 2025.